Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Review

ESI Most Cited Paper International Collaboration

cited authors

  • Liu, Bingwen; Li, Min; Zhou, Zhiguang; Guan, Xuan; Xiang, Yufei

Publication Date

  • July 1, 2020

webpage

published in

category

keywords

  • Coronavirus disease 2019
  • Cytokine release syndrome
  • Interleukin-6
  • Tocilizumab

volume

  • 111